Month: September 2020

EMERYVILLE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Zogenix (Nasdaq: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced the appointments of Caroline M. Loewy, Mary E. Stutts and Denelle J. Waynick to newly created seats on its Board of Directors, effective immediately. Zogenix’s Board now includes 10 members, nine of whom are independent.“We are delighted to welcome Ms. Loewy, Ms. Stutts and Ms. Waynick to our Board of Directors,” said Cam L. Garner, Chairman of the Board. “Their combined decades of experience in the biopharmaceutical industry and extensive knowledge in the areas of patient and rare disease advocacy, investor relations, corporate communications, public affairs, international operations, and legal affairs will prove invaluable to our team as Zogenix...

HAMILTON, Bermuda, Sept. 21, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of clinical-stage assets designed to modulate immunological pathways that are implicated across a spectrum of diseases, today announced that the company will host a virtual Rilonacept Analyst Day on Monday, September 28th, 2020 from 8:00 a.m. to 9:30 a.m. Eastern Daylight Time.The event will feature presentations from the Kiniksa management team on the market opportunity for rilonacept in recurrent pericarditis as well as the company’s continued commercial preparations and launch strategy. Additionally, guest speaker Paul Cremer, MD, Cardiovascular Medicine, Cleveland Clinic, will review the burden of recurrent pericarditis, the current treatment landscape, and the unmet need.Rilonacept...

WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP) to evaluate AB201 for the treatment of patients hospitalized with COVID-19. Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 as early as the fourth quarter of this year.Dr. Michael Bristow, ARCA’s President and Chief Executive Officer, commented, “This IND submission is a key milestone in the clinical development of AB201. With what we believe...

TORONTO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Jade Power Trust (“Jade Power” or the “Trust”) (TSXV:JPWR.UN) announces that the special committee comprised of certain independent directors of the administrator of the Trust (the “Committee”) struck to explore strategic alternatives for the Trust has been disbanded. The formation of the Committee was first announced by the Trust on May 15, 2020. Further, the Trust announces that it has terminated the mandate of the Trust’s financial advisor BAC IP EAD (BAC Securities) to support the evaluation of potential alternatives.J. Colter Eadie, Chief Executive Officer of Jade Power commented, “We thank the Committee members for their work during the tenure of the Committee’s mandate. As noted from our Q2 2020 financial results, the Trust has been achieving record energy generation and profit levels,...

BOCA RATON, Fla., Sept. 21, 2020 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) announced today that, via its commercial channel (“ADT Commercial”), it is investing in Percepta Labs, an artificial-intelligence technology startup out of Philadelphia. ADT Commercial is a premier provider of commercial security, fire, life safety, and risk consulting services in the U.S., and through its investment will fund the commercialization and application of the startup’s cutting-edge AI technology to help detect and deter shoplifting. ADT Commercial will work directly with Percepta to further test and develop the application of Percepta’s proprietary, socially responsible AI technology in commercial environments and facilitate the launch when the solution is market-ready.Founded by Philippe Sawaya, Neil Gramopadhye, and Jonathan Mak while pursuing...

Orlando, Florida, Sept. 21, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, is providing the following media alert to industry press and trade organizations.The company will be announcing details pertaining to an industry-first, global alliance and making its executives/related member-parties available for comment.Date: Monday, September 21, 2020Time: 5:00pm GMT, 12:00pm ET, and 9:00am PTAdditional announcement details will be provided across the below channels:• Further press releases distributed via newswire• On the company’s Press Center: https://izea.com/press• IZEA’s social media handles on Twitter, Facebook, Instagram, and YouTubeCredentialed media interested in speaking with company and/or alliance executives...

Boston, Sept. 21, 2020 (GLOBE NEWSWIRE) — Catastrophe risk modeling firm AIR Worldwide estimates that industry insured losses to onshore property resulting from Hurricane Sally’s winds, storm surge, and inland flood will range from USD 1 billion to USD 3 billion, with wind representing the majority of the losses. AIR Worldwide is a Verisk (Nasdaq:VRSK) business.After meandering across the Gulf, Sally made a late shift eastward and rapidly intensified to a Category 2 hurricane before making landfall at 4:45 a.m. CDT on September 16 near Gulf Shores, Alabama, just west of the Florida border, with maximum sustained winds of 105 mph (165 km/h) and a minimum central pressure of 965 mb. Sally quickly diminished after landfall as it crept northeast at around 3 mph, bringing wind gusts over 100 mph, storm surge of around 6-7 feet above...

INVITATIONWe are pleased to invite you to a presentation of Contextvision AB and its 2nd quarter and half year 2020 figures and give an update on the company’s development and ongoing projects. The presentation will be held as an online webinar on Thursday, September 24th at 11:30.We are very proud of Context Vision’s developments during 2020 and look forward to sharing an update of the major achievements. Fredrik Palm, CEO, and Ann-Charlotte Linderoth, CFO, will represent the management. There will be time for questions after the presentation. You need to register in order to participate at the webinar, please click on the link to sign up:https://www.bigmarker.com/norne-securities-as/ContextVision-Q2-2020-PresentationWe need your registration on September 23rd by the latest.You are most welcome!This information is subject to the disclosure...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” or the “Company“), is pleased to announce that it has received TSX Venture Exchange approval to the issuance of an aggregate of 828,077 Common Shares (the “Total Shares“) to a total of 5 service providers in settlement of an aggregate amount of $54,965.41 owing to the service providers.All Common Shares issued in connection with the debt settlement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. Of the Total Shares, 150,000 (issued at a deemed price of $0.05) will become free trading on September 25, 2020 and the remainder...